chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I went to get up for the bathroom. I had an excruciating pain in my abdomen in the belly button area. I started to walk towards the restroom down the hall, the pain wrapped around my whole waistline all the way around to the back of me. It continued to tighten up and I had trouble walking. I haven't felt pain like that since childbirth. I went to the bathroom and sat there. I had a hard time going to the restroom and my daughter watched after me. I tried to get up and the pain doubled back. It was a sharp pain and had trouble walking back to my living room. I sat there for 45 minutes and thought it went away. I needed to go to the bathroom and went to get up and the pain was worse than the first time. My daughter and husband helped me to the bathroom and the whole time I was in really bad pain that would not go away. They took me to the emergency room. I'm still experiencing abdominal pain. They just called it acute severe abdominal pain. They said that the results showed issues with my blood counts. I will be going to see a doctor on July 22, 2022 for follow up and further diagnosis. This same event happened after my first booster. I started to feel better then the same thing happened with this 4th dose. There have been stomach issues, constipation, and inflammation. I'm concerned about getting this reaction after for future boosters.
potential side effect from the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (potential side effect from the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION COMPLICATION (potential side effect from the vaccine). At the time of the report, VACCINATION COMPLICATION (potential side effect from the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Information has been received from a licensed practical nurse concerning a 65 year old female with high cholesterol, hypertension, osteoarthritis, gastroesophageal reflux disease, prednisone allergy, Terramycin allergy and penicillin allergy, who on 09-NOV-2007 was vaccinated SC on the right deltoid with a single 0.65 mL dose of zoster vaccine live (Oka/Merck) (Lot # 658602/1080U). Concomitant therapy included Diovan HCT, Norvasc, Daypro and a dose of influenza virus vaccine (unspecified). On 12-NOV-2007, the patient developed an injection site reaction. The reaction was described as 2X4 cm raised rash at the injection site area. The area of rash was described as warm, tender and itchy. Unspecified medical attention was sought. No diagnostic laboratory test were undertaken. At the time of report the patient had not recovered. A product quality complaint was not involved. Additional information has been requested. Additional information has been received from the licensed practical nurse concerning this 65 year old white female with cholesterol high, hypertension, osteoarthritis, gastroesophageal reflux disease, prednisone allergy, penicillin allergy, seborrhoeic keratosis, skin tags, acute gastritis, hypertriglyceridaemia, anaemia, diverticular disease and a terramycin allergy who on 09-NOV-2007 at 11:52 was vaccinated SC in the right deltoid with a first dose of zoster vaccine live (Oka/Merck) (lot # 658602/1080U). Concomitant vaccination included a second dose of FLUZONE (lot # U2489AA) given IM in the left deltoid at 11:50. Additional concomitant therapy included DIOVAN HCT, NORVASC, DAYPRO, XALATAN and omega-3 marine triglycerides. Illness at the time of vaccination included a sore throat and post nasal drip. On 12-NOV-2007 the patient experienced injection site warmth, tenderness and pruritis. Below the injection site there was an erythematous pruritic rash. The patient was seen in the office on 12-NOV-2007. At the time of the report the patient had not recovered. Additional information has been requested.
A HCP called our pharmacy today 6/15/23 to notify us that they had verified that the patient received the same vaccine the day before they got the dose here.  The HCP said they got the Bivalent dose on 10/28/22 and then I confirmed that they got the Bivalent dose here on 10/29/22.
Diagnosed pt w/cellulitis in left arm by ER doctor. Is currently under treatment by Dr. has not completed treatment; is improving.
Received Pfizer covid vaccine 1st dose at 1615, c/o lump in throat at 1616, which became worse.  Her HR was also in 120's. At 1618, Epi given x1, then pt transferred to ED
I can count on one hand how many times in 63 years how many times in my life that I have had a headache. On February 27, 2021, I developed a headache on the right frontal aspect of my head deep inside my skull which I would rate at a 2-5/10. After 3 weeks of this headache, I consulted my neurologist who saw me for a visit and ordered an MRI with and without contrast which I had done on April 14 which turned out to be negative. I also started PT  two times a week due to some dizziness which I also developed on February 27. Three days of decadron 4mg twice a day did not relieve the daily headache. My PCP ordered a LYMES titer which was also negative. I also saw my eye doctor who dilated my eyes and did a thorough exam which was also negative. My neurologist has started me on topamax 50mg at night which so far after 3 weeks has not stopped the daily headaches. Two days this past week I had which I would describe as an electric shock down my left arm which lasted 5 minutes. Last night, I had a burning pain encircling my chest as I tried to fall asleep. These symptoms have not caused me as of yet to miss work as a pre and post op nurse which I do 40 hours a week. The only thing in my like which has changed is that I have had the vaccine.
Intense chills followed by 5-minutes of extreme uncontrollable shaking; Other symptoms include fever 102, intense chills, body aches
parotitis first observed 7/18/99 morning, ER visit. saw MD 7/19
Woke up @ 2 AM with Fever/chills vomiting  Muscle pain and body aches . Lasted 6 Hours then severe headache all day Missed work and could not resume daily activities
dry eyes started 2/22/2021.  Symptom persist.  Lake of energyk and general weakness began about the same time. Several months later began having tremors,   Diagnosed with hyperthroidism/graves disease Sept. 2021.  Symptoms all consistent with Graves Disease.
This is a spontaneous report from a contactable consumer. A male patient (the grandson of the consumer) received a dose of PREVENAR 13, which was reported as pneumococcal C, on an unspecified date. The number of previous doses was unspecified. The patient, currently aged 7 years, developed respiratory issues on an unspecified date. The patient's physician reported that he might have missed a dose of pneumococcal C in the past and was considering a supplemental dose. The reporter was not sure of which vaccines were missed. Therapeutic measures taken as a result of the event included treatment with steroids, SINGULAIR and ADVAIR inhaler, for six months. The outcome was unknown. Follow-up (05Aug2011): Follow-up attempts completed. No further information expected.
1 day after ADACEL pt. experienced all over joint pain, a large lump at injection site and redness. She is feeling much better today but arm is still red at injection site.
Tingling of the lips, strange taste of ink, increase BP systolic at 190 diastolic at 105, Heartrate 110-120. On site physician at bedside in recovery area. Emergency services requested due to unresolved symptoms
From telephone contact received on 11/26/01, it was reported by the patient that he was immunized with Fluzone on 11/09/01 and on 11/10/01 developed these spots that started on his hands and spread to other areas of his body. He was evaluated by his physician who informed him what he had was folloculitis-bacterial infection of the skin and was not related to the flu vaccine. The patient feels it was triggered by the flu vaccine. Patient also stated he swims and uses a hot tub in the YMCA which is a public facility. These spots lasted for one week. A dermatologist was not consulted.
First shot July 27 2022 lot 5j27j from same pharmacy.  Felt a little tired 4 hours after shot but by 1030 pm I was shivering, fever 100.3F, bone pain, arm pain... felt like a raging inferno all night. No arm redness until Monday night... but, chills, fever, pain in arm, muscle aches, nausea,... remain to today, Wednesday. I feel awful! Like I have the flu. Negative for.covid. I feel I just want to crawl in bed and stay.... have to take care of house and child. I'm miserable! I did not expect these symptoms for so long. The huge red circle on my arm is about 5 to 6 inches round... hot and itchy.
I had a scratchy throat and a runny nose but no fever. I was feeling hoarse by Tuesday. I took a COVID-19 home test on July 5th and it came back positive. I reported the positive test on the clinic website and received a phone call. I also self isolated. I got a call from the clinic on Wednesday morning and was prescribed PAXLOVID, though the symptoms were pretty mild. I started to feel better within a day. My throat is fine and I no longer have the stuffiness in my head.
In order, chills, nausea, severe vomiting, chest pain, shortness of breath, tingling in hands, headache, fever, swelling under armpit of same arm vaccine received.
pt recvd vax 16AUG95 & had fever that eve of 101.3 R @ 10PM that eve;2NOV95 parents reported that pt devel drooping of lt eyelid & discoloration under lt eye 1-2 wks p/vax;no sx of ptosis noted
Fri. 10/19/2007 8:00a.m. received Fluzone.  Sat. 10/20/2007 at 1:00 p.m. while riding in the car, felt nauseous and had a bad headache. Went to lunch, was able to eat. While driving felt nauseous again and headache was worsening. At first stop, got out of car and laid on the lawn. Then went inside (her mother-in-law's house)and slept for one hour.  Then returned home, took two extra strength Tylenol tablets and slept for three hours more. Then she got up and ate a piece of apple and was recovered.
shingles after first dose of shingrix/herpes zoster outbreak.; soreness/still with a lot of pain; redness; This case was reported by a consumer via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th October 2020, the patient received the 1st dose of Shingrix. On 17th October 2020, 1 days after receiving Shingrix and an unknown time after starting acyclovir, the patient experienced shingles, pain and erythema. The patient was treated with acyclovir. On an unknown date, the outcome of the shingles, pain and erythema were not recovered/not resolved.   It was unknown if the reporter considered the shingles, pain and erythema to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and experienced soreness, redness and an outbreak of Shingles the following day.  The patient took acyclovir twice a week during the herpes zoster outbreak. The patient reports a second outbreak that started on 24th October 2020 and still with a lot of pain. Th reporter did not consent to follow up.
Rash on most of body (most prominent on face, neck, chest, shoulders,  upper abdomen), slight swelling of face, extreme joint pain/tightness is knees, elbows, ankles, and wrists.
Viral syndrome of rhinorrhea, sore throat, decreased appetite, malaise, increased dyspnea
Area of injection became indurated with erythema.  The area is about 3 inches in diameter.  The are is warm to touch.  There is no bruising or hematoma present.
no additional AE reported; administered on 7/7/2021 that has a labeled expiry of 6/30/2021; 41 years old patient; This spontaneous report was received from a physician and refers to a 41-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 07-JUL-2021, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin) (M-M-R II), 0.5 milliliter, lot # S020161, expiry date: 30-JUN-2021 (formulation, route of administration, anatomical location were not reported) for prophylaxis. There were no known temperature excursions. No additional adverse events were reported.
preterm labor; was born 4 to 6 weeks prematurely after she had been administered GARDASIL near the end of the second trimester of pregnancy; high blood pressure; Pregnant patient had been administered GARDASIL near the end of the second trimester of pregnancy; This spontaneous retrospective pregnancy report was received from a 14 years old female patient. The patient's concurrent conditions included asthma. There were not allergies or drug reactions. Her concomitant therapies included  prenatal vitamins. The patient's last menstrual period (LMP) was calculated as 20-JUN-2007.  In approximately in 2008 near the end of the second trimester of pregnancy, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) route "injection",(dose, frequency, vaccination site and dose number were not provided), for prevent human papillomavirus (HPV).  In 2008, the patient experienced high blood pressure a few days after vaccination and she never received another dose of  quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL)  after that. Unspecified bloodwork was done to investigate the high blood pressure but results were not provided.  In 2008, the patient was hospitalized for preterm labor at an unspecified hospital on an unspecified date and the labor was stopped.   The patient gave birth to a male baby who was born 4 to 6 weeks early at 34 weeks of gestation (40 weeks minus 6 considering the worst possible scenario) despite her estimated date of delivery (EDD) was calculated as 26-MAR-2008 (Child case captured in MARRS #1911USA012743) (premature delivery). It was reported that due to the events, she was kept home from school and that she recovered "a little while after giving birth".   At the time of reporting, the outcome of high blood pressure was unknown. The reporter did not provide a causality assessment between Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine(GARDASIL), the premature delivery, premature labor and high blood pressure.; Sender's Comments:  US-009507513-1911USA012743:
About 15 minutes after patient received vaccines mom noted a hive on his right thigh. Varicella vaccine was given at this site 10ml of liquid Benadryl was given, within 10 minutes the hive was resolving
Diarrhea, NauseaVomiting,  stomach cramps and discomfort Narrative:
Left sided facial swelling after receiving an influenza injection at Daycare. No anaphylaxis-or trouble swallowing, or rash.
Heat at injection site; Knot on arm above elbowand it has heat to touch; Redness on arm and shoulder and hot to touch; Redness at injection site; Swelling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Heat at injection site), SKIN MASS (Knot on arm above elbowand it has heat to touch), ERYTHEMA (Redness on arm and shoulder and hot to touch), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE SWELLING (Swelling at injection site) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Heat at injection site), SKIN MASS (Knot on arm above elbowand it has heat to touch), ERYTHEMA (Redness on arm and shoulder and hot to touch), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE SWELLING (Swelling at injection site). At the time of the report, VACCINATION SITE WARMTH (Heat at injection site), SKIN MASS (Knot on arm above elbowand it has heat to touch), ERYTHEMA (Redness on arm and shoulder and hot to touch), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE SWELLING (Swelling at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
With the first vaccine, I had mild symptoms (sore arm, body aches, and headache.   However, 8 days later, I had a large red welt on my arm at the vaccine site. It was warm to the touch and a little itchy. After several days, that was gone and I was left with a small black and blue mark which lasted for a few days. After that, I was fine.  With the second vaccine, I was fine for several hours but about 6 hours after receiving the vaccine, I started getting a headache, had a site arm, and had body aches/pain across my shoulder, up my neck and down my spine. I woke up in the morning with a 102.3 fever, severe body aches, a headache, and burning eyes. My fever finally broke around 6pm.   I woke up the next day with a mildly sore arm and mild body aches. Much better than the day before.
Information has been received from a Licensed Practical Nurse (LPN) concerning a 29 year old patient with unknown gender. On 12-JAN-2015, the patient was inadvertently vaccinated with an expired dose of PNEUMOVAX 23 (0.5 ml, once, lot # J013345, and expiration date: 11-JAN-2015, intramuscular) in the right deltoid (Expired vaccine administered). No adverse effects were reported. Additional information has been requested.
I had aches and pains for about a day after receiving the vaccine. I developed painful eyelids and it hurt to blink. I went to my doctor and was diagnosed with blepharitis. I was given a prescription for an topical antibiotic and a steroid. As of today, I am feeling better.
Patient reported feeling dizzy and weak. Patient had observation time increased from 15 min to 30 minutes. vitals take at start of event and q 15min. BS 123, taken at time of event. After 30 minutes patient reported "feeling fine" and had relief of all complaints. Ambulated out of clinic with steady gait.
First dose / on 10Nov2019. Second had not been administered at time of the call.; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (Received 1st dose on 10th November 2019, batch number JC55P and expiry date 15th November 2021.).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follow: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive his 2nd dose which led to incomplete course of vaccination. The reporter consented to follow up by email.
Had an episode of tounge tingling and numb throat. Lasted 30 min, resolved without any treatment.
Patient started blinking repetitively after receiving vaccine.  Has continued to have repetitive blinking 3-4 time every minute since.  Seen in office on 2/4/2021.
I currently have an iud and haven?t had a period in over 3 years and 7/8 hours after receiving the vaccine I received my period heavily for 6 days.
Inconsolable crying/screaming began about 330PM; Lasted until about 8PM-fell asleep. Woke up about 11PM screaming/crying, generalized shaking lasting 7-10min. Mother thinks had fever temp not measured; 1 or both thighs red,swollen;
missed to receive the 2nd dose on 1May2021 and received that on 21May2021; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (missed to receive the 2nd dose on 1May2021 and received that on 21May2021) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (missed to receive the 2nd dose on 1May2021 and received that on 21May2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (missed to receive the 2nd dose on 1May2021 and received that on 21May2021) had resolved.            No concomitant medications were provided No treatment medications were provided
Received school boosters 11/16/04. 11/17/04 a.m. had 6cm x 4cm area and erythema  at site of MMR. Fever 101F & irrtability. Sent to ER 11/17/04. Tx with Cortizone and Cephalexon. Erythema resolved within 7 days. No further complications
Developed flu-like symptoms after about 10 days, felt better for a day or so, then developed weakness, diarrhea, bladder infection, fever - went to ER, then blood work proved positive for MRSA - 6 weeks of severe weakness - confusion.
The patient has a history of multiple sclerosis. She was seen in the ED on 9/27/23 with worsening shortness of breath and hypoxia that started after testing positive for COVID-19 on 9/18/23. She additionally reported cough, chest tightness, and congestion, and was previously seen in clinic where a chest x-ray showed pneumonia. The patient was admitted 9/27-9/28 with discharge diagnoses including acute hypoxic respiratory failure due to COVID-19 pneumonia versus superimposed bacterial pneumonia. The patient returned to the ED on 9/30/23 with increased work of breathing and acute hypoxemic respiratory failure due to severe COVID-19 and multifocal COVID pneumonia, among other diagnoses. Additionally, the patient was treated for possible bacterial pneumonia during her admission. During her re-admission, the patient did require supplemental oxygen, however by discharge she was weaned down to room air at rest and 3 L with exertion. Additionally, she completed a 10-day course of Paxlovid on 10/20/23 and a 10-day course of IV Remdesivir on 10/19/23.    Of note, the patient did receive four doses of the Moderna monovalent COVID vaccine (given 3/25/2021; 4/22/2021; 9/3/2021; 5/19/2022) and one dose of the Moderna bivalent COVID vaccine (given 10/20/2022).
Developed fever, nausea, headache, and body aches 8-9 hours after receiving vaccination.
Vaginal bleeding for about 20 days, following the COVID vaccine. I received the vaccine at 10:30 a.m., and started bleeding around 8 p.m. The bleeding last about 10 days, stopped for 2 days, and started again for another 7 days. It was accompanied by cramping and abdominal pain.
blood clots; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 2023USL00904.  A 67-year-old female patient received bnt162b2 (BNT162B2), in Apr2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 65 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: THROMBOSIS (medically significant), outcome "unknown", described as "blood clots". Clinical course: On 27Oct2023, it was reported that in Apr2021, a patient received the Pfizer COVID-19 shot. Subsequently, on an unreported date, the patient developed blood clots.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.